2023-2024 Regular Session • US Congress Legislature
HB6301: Cancer Drug Parity Act of 2023
Legislative Summary
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
Bill History
11/8/2023
Introduced in House
House of Representatives
11/8/2023
Referred to the House Committee on Education and the Workforce.
House of Representatives
Status Information
Current Status
Introduced(11/8/2023)
Chamber
House of Representatives
Committee
Education And The Workforce(House of Representatives)
Sponsors
Republican: 4
Democrat: 24
Primary Sponsor

Glenn Grothman
Republican
Co-Sponsors (27)
Suzanne Bonamici
Democrat
Gus Bilirakis
Republican
Brian Higgins
Democrat
Brian Fitzpatrick
Republican
Joseph Morelle
Democrat
Doris Matsui
Democrat
Colin Allred
Democrat
Julia Brownley
Democrat
Jimmy Panetta
Democrat
Yvette Clarke
Democrat
Gerald Connolly
Democrat
Kathy Castor
Democrat
David Trone
Democrat
Nanette Barragan
Democrat
Jamie Raskin
Democrat
Ann Kuster
Democrat
Grace Napolitano
Democrat
Christopher Pappas
Democrat
Bill Posey
Republican
Derek Kilmer
Democrat
Yadira Caraveo
Democrat
Gwen Moore
Democrat
Ted Lieu
Democrat
John Larson
Democrat
Donald Davis
Democrat
Abigail Spanberger
Democrat
Sharice Davids
Democrat